Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Kelatorphan"'
Autor:
Xavier Nadal, Marie-Claude Fournie-Zaluski, Rafael Maldonado, Hervé Poras, Bernard P. Roques, Elisabeth Bonnard
Publikováno v:
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, 2015, 3 (2), ⟨10.1002/prp2.116⟩
Recercat. Dipósit de la Recerca de Catalunya
instname
Pharmacology Research & Perspectives, Wiley, 2015, 3 (2), ⟨10.1002/prp2.116⟩
Pharmacology Research & Perspectives, 2015, 3 (2), ⟨10.1002/prp2.116⟩
Recercat. Dipósit de la Recerca de Catalunya
instname
Pharmacology Research & Perspectives, Wiley, 2015, 3 (2), ⟨10.1002/prp2.116⟩
International audience; The peripheral endogenous opioid system is critically involved in neuropathic and inflammatory pain generation as suggested by the modulation of opioid receptors expression and enkephalins (ENKs) release observed in these pain
Autor:
Stephen G. Davies, Darren J. Dixon
The first asymmetric synthesis of Kelatorphan-like enkephalinase inhibitor (1S,2R,2′S)-2-[2′-(N-hydroxycarbamoylmethyl)-3′- phenylpropionylamino]cyclohexane-1-carboxylic acid is achieved using lithium amide (R)-5 and pyrrolidinone auxiliary (R)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd8e9a727bca57a5a28e2609a1a0847
https://doi.org/10.1039/a804660c
https://doi.org/10.1039/a804660c
Autor:
Stanley M. Crain, Ke-Fei Shen
Publikováno v:
Brain Research. 1231:16-24
Systemic (s.c.) injection in naive mice of cyclic AMP-phosphodiesterase (cAMP-PDE) inhibitors, e.g. 3-isobutyl-1-methylxanthine [(IBMX) or caffeine, 10 mg/kg] or the more specific cAMP-PDE inhibitor, rolipram (1 μg/kg), rapidly evokes thermal hypera
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas D. Penning
Publikováno v:
Current Pharmaceutical Design. 7:163-179
Leukotriene A4 (LTA4) hydrolase is a zinc-containing enzyme which stereospecifically catalyzes the hydrolysis of the epoxide LTA4 to the diol leukotriene B4 (LTB4). There is substantial evidence that LTB4 plays a significant role in the amplification
Autor:
Gwen Grabowski Krivi, E.Yvonne Pyla, Stevan W. Djuric, Thomas D. Penning, Richard A. Haack, Leslie J Askonas, Stella S. Yu, Marshall L. Michener
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2517-2522
The hydroxamic acid-containing peptide kelatorphan, a known inhibitor of enkephalin-degrading enzymes, is a potent, non-competitive inhibitor of leukotriene A4 (LTA4) hydrolase. Analogs of kelatorphan were prepared and several significantly and selec
Publikováno v:
Psychopharmacology. 120:347-355
The aim of this study is to analyze further the opioid receptor subtypes involved in the augmentation of behavioral activity after dopamine depletion in the nucleus accumbens of rats. Initially, the opioid receptors involved in the augmentation of lo
Autor:
Yaeko Tsukahara, Yasuo Matsumura, Akiko Murakami, Kimi Takada, Takayo Kojima, Satoshi Murata, Masanori Takaoka, Shiro Morimoto
Publikováno v:
Biological and Pharmaceutical Bulletin. 18:401-406
Using cultured human aortic endothelial cells, we examined the effects of phosphoramidon, an endothelin converting enzyme (ECE) inhibitor, on the release of endogenous endothelin-1 (ET-1) and big endothelin-1 (big ET-1), and on the generation of ET-1
Publikováno v:
European Journal of Pharmacology. 264:61-67
The antinociceptive effect of i.v. kelatorphan (2.5, 5, 10 and 15 mg/kg), a mixed inhibitor of enkephalin degrading enzymes, was studied in a rat model of peripheral unilateral mononeuropathy (chronic constriction of the common sciatic nerve). Kelato
Autor:
M. L. Michener, L. J. Askonas, T. D. Penning, Gwen Grabowski Krivi, S. W. Djuric, E. Y. Pyla, Richard A. Haack, Stella S. Yu
Publikováno v:
ChemInform. 27